Cargando…
Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant
Liver transplant is the unique curative therapy for patients with acute liver failure or end-stage liver disease, with or without hepatocellular carcinoma. Increase of body weight, onset of insulin resistance and drug-induced alterations of metabolism are reported in liver transplant recipients. In...
Autores principales: | Gitto, Stefano, Villa, Erica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848946/ https://www.ncbi.nlm.nih.gov/pubmed/27049380 http://dx.doi.org/10.3390/ijms17040490 |
Ejemplares similares
-
Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives
por: Gitto, Stefano, et al.
Publicado: (2018) -
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease
por: Sartini, Alessandro, et al.
Publicado: (2018) -
The Other Side of Malnutrition in Inflammatory Bowel Disease (IBD): Non-Alcoholic Fatty Liver Disease
por: Gibiino, Giulia, et al.
Publicado: (2021) -
Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
por: Battistella, Sara, et al.
Publicado: (2023) -
Metabolic drivers of non-alcoholic fatty liver disease
por: Bence, Kendra K., et al.
Publicado: (2020)